2 terminated. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 3 | 2 | Terminated 2 |
Follow Usher Syndrome Type 2: new trials by email Literature Review of Usher Syndrome Type 2 trials Research Report on Usher Syndrome Type 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste) QR-421a, Sham-procedure - Retinitis Pigmentosa, Usher Syndrome Type 2 | Phase 2 / Phase 3 | Terminated | Laboratoires Thea | 5 | 2021-12-15 | 2024-08-07 |
| Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius) Ultevursen, Sham-procedure - Retinitis Pigmentosa, Usher Syndrome Type 2 | Phase 2 / Phase 3 | Terminated | Laboratoires Thea | 7 | 2021-12-08 | 2024-07-12 |
Eye Abnormalities (2) · Eye Diseases (2) · Eye Diseases, Hereditary (2) · Retinal Diseases (2) · Retinitis Pigmentosa (2) · Usher Syndromes (2) · Vision Disorders (2)
Abnormalities, Multiple (2) · Blindness (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Deaf-Blind Disorders (2) · Deafness (2) · Ear Diseases (2) · Genetic Diseases, Inborn (2) · Hearing Disorders (2) · Hearing Loss (2) · Hearing Loss, Sensorineural (2) · Nervous System Diseases (2) · Neurologic Manifestations (2) · Otorhinolaryngologic Diseases (2) · Pathological Conditions, Signs and Symptoms (2)
United Kingdom (2) · United States (2) · Germany (1) · Netherlands (1)